Physician profile
Jane D Lim
NPI 1699778050
$4,187.62
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $628 · 2021: $1,428 · 2022: $902.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,013.94 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $479.34 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $444.65 | 2019-2022 | |
| Genzyme Corporation | $389.65 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $209.81 | 2019-2022 | |
| Janssen Biotech, INC. | $200.96 | 2019-2022 | |
| Amgen INC. | $165.10 | 2019-2022 | |
| Lilly USA, LLC | $159.69 | 2019-2022 | |
| Dermira, INC. | $132.58 | 2019 | |
| Celgene Corporation | $115.91 | 2019 | |
| Genentech USA, INC. | $108.58 | 2019-2021 | |
| Pfizer INC. | $104.80 | 2019-2022 | |
| Vyne Pharmaceuticals INC. | $103.33 | 2020-2021 | |
| Ucb, INC. | $101.46 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $95.96 | 2020-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $95.54 | 2019 | |
| Leo Pharma INC. | $86.38 | 2019-2022 | |
| Incyte Corporation | $67.78 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.38 | 2022 | |
| Almirall LLC | $21.18 | 2019 | |
| Aclaris Therapeutics, INC. | $14.54 | 2019 | |
| Merck Sharp & Dohme LLC | $12.14 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $11.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.